This is the main Genocea Biosciences Inc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. 2019/12/27 · View today's stock price, news and analysis for Genocea Biosciences Inc. GNCA. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.
2019/12/27 · Genocea Biosciences, Inc. engages in the development and commercialization of cancer vaccines. It uses its proprietary technology platform ATLAS, to identify clinically relevant antigens of T cells based on actual. Stock quote for Genocea Biosciences, Inc. Common Stock Common Stock GNCA with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. Our Businesses Solutions Quotes.
2019/10/24 · Find the latest Genocea Biosciences, Inc. GNCA stock quote, history, news and other vital information to help you with your stock trading and investing. Genocea to Present at the Stifel 2019 Healthcare Conference. GNCA Genocea Biosciences, Inc. Common Stock Data is currently not available DATA AS OF Dec 13, 2019 $2.19 0.02 0.9% GNCA Genocea Biosciences, Inc. Common Stock GNCA News Headlines Genocea Biosciences. View detailed financial information, real-time news, videos, quotes and analysis on Genocea Biosciences Inc. NASDAQ:GNCA. Explore commentary on Genocea Biosciences Inc. and hear what the experts at TheStreet are saying.
Genocea Biosciences has a market capitalization of $54.13 million and generates $230,000.00 in revenue each year. The biotechnology company earns $-27,810,000.00 in net income profit each year or $3.68 on an earnings per. Genocea Biosciences has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. GNCA: 2.13 -2.29% Genocea Preclinical Data at SITC Demonstrate that Inhibitory Neoantigens in an Otherwise Protective Vaccine Reverse Anti-Tumor Responses GlobeNewswire - Sat Nov 9, 8:00AM CST. The Investor Relations website contains information about Genocea Biosciences business for stockholders, potential investors, and financial analysts. Genocea is a biopharmaceutical company developing personalized cancer. Genocea Biosciences, Inc. Common Stock GNCA Latest Real Time Trades Nasdaq 12/6/2019 Genocea Biosciences Inc GNCA CEO Chip Clark on Q3 2019 Results Earnings Call - Transcript 10/28/2019 11/9/2019 11/14.
5 Wall Street analysts have issued ratings and price targets for Genocea Biosciences in the last 12 months. Their average twelve-month price target is $16.33, suggesting that the stock has a possible upside of 689.05%. The high. View the real-time GNCA price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Genocea.
CAMBRIDGE, Mass., June 19, 2019 GLOBE NEWSWIRE -- Genocea Biosciences, Inc. NASDAQ: GNCA, a biopharmaceutical company developing personalized cancer immunotherapies, today announced the pricing of its. GNCA Real Time Stock Quote - Get Genocea Biosciences, Inc. Common Stock GNCA last sale data in real-time at. Our Businesses Solutions Quotes Quotes & Research Flash Quotes InfoQuotes Real-time. Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, to recall a patient's pre-existing CD4 and CD8 T cell. Learn about GNCA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on GNCA. 2019/10/24 · Find the latest Genocea Biosciences, Inc. GNCA stock quote, history, news and other vital information to help you with your stock trading and investing. Stonewall chair on how her worst ever job also ‘rescued’ her.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Get Genocea Biosciences Inc GNCA:NASDAQ real-time stock quotes, news and financial information from CNBC. × SIGN IN Pro Watchlist Make It Select USA INTL Markets Pre-Markets U.S. Markets Currencies Bonds. 2019/06/20 · Genocea Biosciences NASDAQ:GNCA has priced its public offering of 10.5M common shares at $3.50/share, for gross proceeds of $36.75M. Underwriters over-allotment is an additional 1.58M common shares. Closing. Genocea Biosciences GNCA Stock Soars on Positive Trial Results By Amanda Albright Mar 31, 2016 10:06 AM EDT OPINION 5 stocks under $10 set to soar higher By.
Ipad AirとIpad 2018を比較
Td Branch Locator
Panera Mobile Order Coupon
Pixel 2 Xl vs Samsung S9 Plus
Raazi映画からのAe Watan Song
Bad PcのApex Legends
Louis Vuitton Monogram Canvas Artsy Mm Bag
Digit Car Insuranceの商品ユーザーレビュー
2019 Acc Men's Basketball Tournament Location
Openvpn Connect Apkダウンロード
Samsung Galaxy S10e S10 S10
Apple Ipad ProとGalaxy Tab S4